🔗 Visit the ClinicalTrials.gov page for NCT00108953
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. | JAMA | 2010 | 4.71 |
| 2 | Reporting of results in ClinicalTrials.gov and high-impact journals. | JAMA | 2014 | 2.10 |
| 3 | Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. | Hepatology | 2013 | 0.86 |